Explore more Articles in

BioTech

Calidi Biotherapeutics Stock Jumps 39% After Hours — What’s Going On – Calidi Biotherapeutics (AMEX:CLDI), Mustang Bio (NASDAQ:MBIO)

Calidi Biotherapeutics Inc. CLDI stock surged by 39.47% in the after-hours trading session on Tuesday. The stock price increased by $0.095, reaching $0.34. The...

Illiquid, Overvalued Assets Spark Market Fears as Buyers Retreat

As "dip buyers" get eviscerated, more dominos fall, and at a tipping point, the herd realizes the tide has reversed and it’s time to...

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks – Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical...

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a session volume of 160.9 million compared to the average volume of 4.03 million...

Aardvark’s Hunger-Suppressing Drug Promises Weight Loss Without GI Distress – Aardvark Therapeutics (NASDAQ:AARD)

HC Wainwright initiated coverage on Aardvark Therapeutics, Inc. AARD on Monday with a Buy rating and a price forecast of $40.In February, Aardvark Therapeutics,...

Vor Biopharma’s $125 Million Investment Paves Way For Multi-Billion Dollar Autoimmune Market – Vor Biopharma (NASDAQ:VOR)

H.C. Wainwright upgraded Vor Biopharma Inc. VOR, highlighting the company’s “rebirth” following the in-licensing of telitacicept.On Thursday, the company announced a strategic licensing agreement...

FDA Flags Major Safety Concerns For Argenx’s Nerve Disorder Drug, Stock Falls – argenx (NASDAQ:ARGX)

Argenx SE ARGX stock is trading lower on Monday after the U.S. Food and Drug Administration (FDA) signaled serious risks/safety identified by the reporting...

Alzheimer’s Setback Hits INmune Bio Stock, But FDA Hopes Remain – INmune Bio (NASDAQ:INMB)

INmune Bio Inc. INMB stock is trading lower on Monday, with a session volume of 23.2 million, compared to the average volume of 1.45...

Why Is Micro-Cap Artelo Biosciences Stock Trading Higher On Monday? – Artelo Biosciences (NASDAQ:ARTL)

Artelo Biosciences, Inc. ARTL stock is trading higher on Monday, with a session volume of 11.7 million, compared to the average volume of 70.3K, as...

FDA Raises Manufacturing Concerns, Delays Unicycive’s Kidney Disease Drug Approval – Unicycive Therapeutics (NASDAQ:UNCY)

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) on Monday for Unicycive Therapeutics, Inc.’s UNCY New Drug Application (NDA)...

- A word from our sponsors -

Most Popular